1. Home
  2. MRVI vs BETR Comparison

MRVI vs BETR Comparison

Compare MRVI & BETR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.41

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Logo Better Home & Finance Holding Company

BETR

Better Home & Finance Holding Company

HOLD

Current Price

$37.33

Market Cap

538.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
BETR
Founded
2014
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
472.8M
538.7M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MRVI
BETR
Price
$3.41
$37.33
Analyst Decision
Buy
Buy
Analyst Count
4
1
Target Price
$4.13
$40.00
AVG Volume (30 Days)
1.9M
517.6K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$185,743,000.00
N/A
Revenue This Year
$12.44
$54.06
Revenue Next Year
$7.90
$66.68
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$10.81
52 Week High
$4.11
$94.06

Technical Indicators

Market Signals
Indicator
MRVI
BETR
Relative Strength Index (RSI) 60.33 54.97
Support Level $3.25 $26.89
Resistance Level $3.99 $41.23
Average True Range (ATR) 0.17 3.39
MACD 0.07 0.17
Stochastic Oscillator 81.08 48.02

Price Performance

Historical Comparison
MRVI
BETR

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About BETR Better Home & Finance Holding Company

Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.

Share on Social Networks: